Global Neurological Biomarkers Market 2016-2020
SKU ID :TNV-10293327 | Published Date: 08-Sep-2016 | No. of pages: 68Description
TOC
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Biomarker assays kits
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis:
PART 06: Market segmentation by indication
• AD
• PD
• ASD
• MS
PART 07: Market segmentation by application
• Genomics-based biomarkers
• Proteomics-based biomarkers
• Metabolomics-based biomarkers
• Imaging-based biomarkers
• Emerging application areas
PART 08: Market segmentation by services
• Services
PART 09: Market segmentation by end-user
• Hospitals
• Diagnostic and research laboratories
PART 10: Geographical segmentation
• Neurological biomarkers market in Americas
• Neurological biomarkers market in EMEA
• Neurological biomarkers market in APAC
PART 11: Market drivers
• Increasing low-cost clinical trials in developing countries
• Growing personalized medicine for neurological disorders
• Increasing focus toward drug discovery applications
PART 12: Impact of drivers
PART 13: Market challenges
• Unmet market needs of effective validation of biomarkers
• Reproducibility of biomarkers and tests leading to discrepancies
• Delay in market launch
PART 14: Impact of drivers and challenges
PART 15: Market trends
• Integrated biology approach will be the key focus area
• Development of novel radiotracers for neuro biomarkers that aid diagnostic and clinical applications for diseases
• Evolution of miRNA
PART 16: Vendor landscape
• Competitive scenario
PART 17: Key vendor analysis
• Geographic presence — Key vendor analysis
• Myriad RBM
• Proteome Sciences
• QIAGEN
• Thermo Fisher Scientific
• Other prominent vendors
PART 18: Appendix
• List of abbreviations
PART 19: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Key biomarker technology platforms
Exhibit 03: Global neurological biomarkers market (2016-2020) ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Market segmentation by indication
Exhibit 06: Market opportunities in the major indications
Exhibit 07: Global neurological biomarkers market segmentation by application 2015
Exhibit 08: Market opportunities in key applications
Exhibit 09: Impact mapping of neurological biomarker services
Exhibit 10: Opportunity analysis of biomarker services
Exhibit 11: Global neurological biomarkers market 2015
Exhibit 12: Market overview in Americas 2015
Exhibit 13: Neurological biomarkers market in Americas ($ billions)
Exhibit 14: Market overview in EMEA 2015
Exhibit 15: Neurological biomarkers market in EMEA ($ billions)
Exhibit 16: Market overview in APAC 2015
Exhibit 17: Neurological biomarkers market in APAC ($ millions)
Exhibit 18: Impact of drivers
Exhibit 19: Impact of drivers and challenges
Exhibit 20: Competitive structure analysis of global neurological biomarkers market 2015
Exhibit 21: Market penetration of key neurological biomarkers manufacturers 2015
Exhibit 22: Strategic success factors of companies in global neurological biomarkers market
Exhibit 23: Regional analysis of key vendors
Exhibit 24: Myriad RBM: Profile
Exhibit 25: Myriad RBM: Strength analysis
Exhibit 26: Myriad RBM: Growth strategy matrix
Exhibit 27: Myriad RBM: Opportunity assessment analysis
Exhibit 28: Proteome Sciences: Profile
Exhibit 29: Proteome Sciences: Strength analysis
Exhibit 30: Proteome Sciences: Growth strategy matrix
Exhibit 31: Proteome Sciences: Opportunity assessment
Exhibit 32: QIAGEN: Profile
Exhibit 33: QIAGEN: Strength analysis
Exhibit 34: QIAGEN: Growth strategy matrix
Exhibit 35: QIAGEN: Opportunity assessment
Exhibit 36: Thermo Fisher Scientific: Profile
Exhibit 37: Thermo Fisher Scientific: Strength analysis
Exhibit 38: Thermo Fisher Scientific: Growth strategy matrix
Exhibit 39: Thermo Fisher Scientific: Growth opportunity assessment
Tables & Figures
Companies
Myriad RBM, Proteome Sciences, QIAGEN, Thermo Fisher Scientific, AbaStar MDx, Abiant, Acumen Pharmaceuticals, Aepodia, Alseres Pharmaceuticals, Athena Diagnostics, Banyan Biomarkers, Cisbio Bioassays, Diagenic, Proteosys, Psynova Neurotech.
- PRICE
-
$2500$4000